Guillaume Pfefer is the founder of Senda Biosciences. Senda Biosciences has raised $226M in total funding. Latest round: Series C.
Guillaume Pfefer is the Co-founder and former CEO of Senda Biosciences, a Cambridge, Massachusetts-based biotechnology company focused on programmable medicines and intersystems biology. He led the company through three major funding rounds, raising a total of $226 million before Senda merged with Laronde in late 2023 to form Sail Biomedicines.
Full founder directory · Investor directory · Company funding database · Fundraising library